Investigating how kratom affects oxycodone metabolism and effects

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the interaction between kratom, a botanical product, and the opioid oxycodone. Healthy adult participants will undergo four different treatment arms, receiving either kratom, oxycodone, or both in various combinations. The primary focus is to assess how kratom influences the metabolism of oxycodone and its effects on the body, particularly through measuring pupil diameter as an indicator of opioid effects. Participants will be closely monitored to gather data on pharmacokinetics and pharmacodynamics.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Males and females, aged from 21-45 years and healthy
* Body weight between 130 and 250 pounds (60-115 kg) and body mass index between 19 and 30
* Not taking any medications (prescription and non-prescription) or dietary supplements/botanical products known to alter the pharmacokinetics of either oxycodone or kratom
* Willing to abstain from consuming dietary supplements/botanical products and fruit juices for several weeks
* Willing to abstain from cannabis/marijuana, hemp, and THC- and/or CBD-containing products for several weeks
* Willing to abstain from consuming caffeinated beverages or other caffeine-containing products the evening before and morning of any inpatient visit
* Willing to abstain from consuming alcoholic beverages for one day prior to any inpatient visit
* Willing to use an additional method of contraception that does not include oral contraceptive pills, patches, or other hormonal methods (such as abstinence, copper IUD, or condoms)
* Have consumed kratom previously and tolerated it well without any unpleasant effects
* Willing to abstain from kratom for several weeks
* Have consumed any opioid previously and tolerated it well without any unpleasant effects or addiction
* Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for the subject to comply with the requirements of the study
* Geographically located within a 40-mile radius of Spokane and have the time to participate

Exclusion Criteria:

* Males and females under the age of 21 or over the age of 45
* People who weigh less than 130 pounds or more than 250 pounds
* People with a body mass index less than 19 or greater than 30
* Any current major illness or chronic illness including but not limited to kidney disease, hepatic disease, diabetes mellitus, hypertension, coronary artery disease, chronic obstructive pulmonary disease, cancer, or HIV/AIDS
* No previous exposure to kratom
* No previous exposure to an opioid
* History of anemia or any other significant hematologic disorder
* History of substance abuse, dependence, or addiction or major psychiatric illness
* A need for chronic opioid analgesics
* Use of opioid analgesics 3 weeks prior to initiation of the study
* An imminent likely need for opioid analgesics (e.g., planned dental or surgical procedure)
* Pregnant or nursing
* History of allergy or intolerance to kratom, other opioids, or oxycodone
* Taking concomitant medications, both prescription and non-prescription (including dietary supplements/botanical products), known to alter the pharmacokinetics of kratom or oxycodone
* Presence of a condition or abnormality that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data
* History of sleep apnea
* Any prior use of amphetamines, benzodiazepines, cocaine, MDMA, opioids, PCP, or other drugs for recreational purposes
* Use of cannabis/marijuana, hemp, THC-containing products, CBD-containing products, or CBD within the last month
* Out-of-range clinical laboratory value that the study physician considers participation in the study a health risk
* Inability to speak, read, and understand English

Where it's running

• Washington State University College of Pharmacy and Pharmaceutical Sciences
  Spokane, Washington, United States Recruiting

Study contacts

• Study coordinator: Mary Paine, PhD
• Email: mary.paine@wsu.edu
• Phone: 509-358-7759

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sleep loss and circadian misalignment and insulin resistance: how cortisol timing might help

  This study tests whether changing cortisol timing with hormones and sleep schedules can influence insulin resistance in healthy adults who sleep restrictively.

  Recruiting Phase 4 Washington State University · Spokane, Washington · NCT07494084

• Hemp-derived cannabinoids for menopause and perimenopause symptom relief

  This will try hemp-derived cannabinoids versus placebo to see if they reduce physical and psychological symptoms in women aged 40–60 going through perimenopause or menopause.

  Recruiting Phase 2 Washington State University · Pullman, Washington · NCT07393672

• Acute Cannabis Effects on Thinking and Mood

  This study tests whether a moderate 20 mg dose of THC affects mood and thinking in adults who use cannabis weekly, using a randomized, placebo-controlled crossover design.

  Recruiting Phase 1 Washington State University · Pullman, Washington · NCT07296874

• TMS to help recovery in people with opioid and alcohol use disorders

  This study tests whether short daily TMS sessions can help people with opioid and alcohol use disorders improve recovery outcomes when added to their regular treatment.

  Recruiting Washington State University · Portland, Oregon · NCT07171359

• Engaging families in coordinated care for early psychosis

  This study is testing a new way to help families get more involved in the care of their loved ones with early psychosis to see if it improves support and outcomes for everyone involved.

  Recruiting at 3 sites Washington State University · Bend, Oregon and 3 other locations · NCT06945055

• Evaluating how oregano affects drug metabolism

  This study is testing whether taking oregano supplements affects how the body processes certain medications in healthy adults.

  Recruiting Early Phase 1 Washington State University · Spokane, Washington · NCT06693960

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.